Package Leaflet: Information for the User
Ibuprofeno Vegal 600 mg film-coated tablets EFG
Ibuprofen
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
Ibuprofeno Vegal belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
This medicine is used to treat fever, pain of mild to moderate intensity including migraine, arthritis (inflammation of the joints, including those in the hands and feet, leading to swelling and pain), juvenile rheumatoid arthritis, osteoarthritis (a chronic disorder that causes cartilage damage), ankylosing spondylitis (inflammation that affects the joints of the spine), non-rheumatic inflammation, and primary dysmenorrhea (painful menstruation).
Do not take Ibuprofeno Vegal:
Warnings and precautions:
Consult your doctor before starting to take Ibuprofeno Vegal:
Ibuprofen has been reported to cause signs of allergic reaction to this medicine, such as respiratory problems, swelling of the face and neck area (angioedema), and chest pain. Stop using ibuprofen immediately and contact your doctor or the medical emergency service immediately if you observe any of these signs.
It is important that you use the smallest dose that relieves-controls the pain and do not take this medicine for longer than necessary to control your symptoms.
Skin reactions
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment. Discontinue treatment with the medicine and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Precautions in elderly patients
Elderly patients have a higher frequency of adverse reactions to NSAIDs (non-steroidal anti-inflammatory drugs), especially gastrointestinal bleeding and perforation, which can be fatal.
Cardiovascular precautions
Anti-inflammatory/analgesic medicines like ibuprofen may be associated with a small increased risk of heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking this medicine if:
Similarly, these types of medicines can cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
Respiratory disorders
Ibuprofen should be used with caution when administered to patients who have or have had bronchial asthma, chronic rhinitis, or allergic diseases, as ibuprofen has been reported to cause bronchospasm, urticaria, or angioedema in these patients.
Infections
Ibuprofen may mask the signs of an infection, such as fever and pain. Consequently, this medicine may delay appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medicine while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Children and adolescents
There is a risk of kidney failure in dehydrated children and adolescents.
The use of this medicine is not recommended in children and adolescents under 14 years of age, as the dose of ibuprofen it contains is not suitable for the recommended dosage in these patients.
Precautions during pregnancy and in women of childbearing age
Because the administration of ibuprofen-like medicines has been associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer it during the first and second trimester of pregnancy unless it is strictly necessary. In these cases, the dose and duration will be limited to the minimum possible.
In the third trimester, the administration of ibuprofen is contraindicated.
For women of childbearing age, it should be taken into account that ibuprofen-like medicines have been associated with a decrease in fertility.
Interference with laboratory tests
If you are going to have any diagnostic tests (including blood tests, urine tests, skin tests using allergens, etc.), inform your doctor that you are taking this medicine, as it may alter the results.
Other medicines and Ibuprofeno Vegal
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Ibuprofen may affect or be affected by other medicines. For example:
Other medicines may also affect or be affected by treatment with ibuprofen. Therefore, you should always consult your doctor or pharmacist before using this medicine with other medicines.
Taking Ibuprofeno Vegal with food, drinks, and alcohol
You can take it alone or with food. In general, it is recommended to take it during meals or with milk to reduce the possibility of stomach discomfort.
Consuming alcohol during treatment may increase the risk of adverse gastrointestinal reactions.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take ibuprofen if you are in the last 3 months of pregnancy, as it may harm the fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your and your baby's ability to bleed and delay or prolong delivery more than expected. You should not take ibuprofen during the first 6 months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time. From the 20th week of pregnancy, ibuprofen may cause kidney problems in your fetus if taken for more than a few days, which may cause low levels of amniotic fluid surrounding the baby (oligohydramnios). If you need treatment for more than a few days, your doctor may recommend additional monitoring. Ibuprofen and its degradation products are excreted in minimal amounts in breast milk. As no adverse effects are known in the infant, it is not usually necessary to interrupt breastfeeding during short-term use at recommended doses. Therefore, if you become pregnant or are breastfeeding, consult your doctor.
Driving and using machines
If you experience dizziness, vertigo, vision disturbances, or other symptoms while taking this medicine, do not drive or use hazardous machinery. If you only take one dose of ibuprofen or for a short period, it is not necessary to take special precautions.
Ibuprofeno Vegal contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will indicate the duration of treatment with Ibuprofeno. Do not suspend treatment beforehand, as this will not achieve the expected results. Similarly, do not use this medication for longer than indicated by your doctor.
The lowest effective dose should be used for the shortest time necessary to alleviate symptoms. If you have an infection, consult a doctor immediately if symptoms (such as fever and pain) persist or worsen (see section 2).
Adults
In adults and adolescents from 14 to 18 years, take one tablet (600 mg) every 6 to 8 hours, depending on the intensity of the condition and response to treatment.
In some cases, higher doses may be required, but in any case, it is recommended not to exceed the maximum daily dose of 2400 mg in adults and 1600 mg in adolescents from 12 to 18 years.
Elderly patients
In elderly patients, the dosage should be established by the doctor, as it may be necessary to reduce the usual dose.
Patients with kidney and/or liver disease
If you have kidney and/or liver disease, your doctor may prescribe a lower dose than usual. If so, take the exact dose prescribed by your doctor.
Use in children and adolescents
The use of this medication is not recommended in children or adolescents under 14 years, as the dose of ibuprofen it contains is not suitable for the recommended dosage in these patients.
Adolescents over 14 years will follow adult dosage recommendations, but the maximum recommended daily dose in these patients is 1600 mg.
This medication is administered orally.
If gastric discomfort is detected after taking the medication, it should be administered together with milk or during meals.
If you think the action of this medication is too strong or too weak, inform your doctor or pharmacist.
If you take more Ibuprofeno Vegal than you should
If you have taken more ibuprofen than you should, or if a child has accidentally ingested the medication, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested, or go to the nearest hospital to find out about the risk and ask for advice on the measures to be taken.
Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain bloody sputum), headache, ringing in the ears, confusion, and involuntary eye movement. In addition to a drop in blood pressure, kidney function disorders and loss of consciousness may occur. At high doses, symptoms of drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness, and dizziness, blood in the urine, chills, and breathing difficulties have been reported.
In cases of significant overdose, kidney failure and liver damage may occur.
It is rare for more severe symptoms to appear, such as intestinal bleeding, low blood pressure, low body temperature, metabolic acidosis, convulsions, altered kidney function, coma, dyspnea/acute adult respiratory distress syndrome, and transient respiratory arrest in children (after ingesting large amounts).
If severe poisoning has occurred, the doctor will take the necessary measures.
In case of ingestion of significant amounts, activated charcoal should be administered. Gastric lavage will be considered if large amounts have been ingested and within 60 minutes after ingestion.
If you forget to take Ibuprofeno Vegal
Do not take a double dose to make up for forgotten doses.
If you forget to take your corresponding dose, take it as soon as you remember. However, if the time for the next dose is near, skip the forgotten dose and take the next dose at the usual time.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause adverse effects, although not all people will experience them.
Adverse effects of medications like ibuprofeno are more common in people over 65 years.
The incidence of adverse effects is lower in short treatments and if the daily dose is below the maximum recommended dose.
Frequencies are established according to the following classification: very frequent (may affect more than 1 in 10 patients); frequent (may affect up to 1 in 10 patients); uncommon (may affect up to 1 in 100 patients); rare (may affect up to 1 in 1,000 patients); very rare (may affect up to 1 in 10,000 patients); frequency not known (cannot be estimated from available data).
The following adverse effects have been observed:
Infections and infestations
Very rare: Exacerbation of inflammation-related infections (e.g., development of necrotizing fasciitis), coinciding with the use of non-steroidal anti-inflammatory drugs.
Note: If signs of infection or worsening occur during treatment with ibuprofeno, it is recommended to go to the doctor immediately, in case antibiotic therapy needs to be initiated.
Gastrointestinal disorders
The most frequent adverse effects that occur with medications like ibuprofeno are gastrointestinal: peptic ulcers, gastrointestinal bleeding, perforations (in some cases fatal), especially in elderly patients. Gastrointestinal disorders such as heartburn, abdominal pain, nausea, vomiting, flatulence, diarrhea, constipation, and mild gastrointestinal bleeding that can cause anemia in exceptional cases have also been observed. Uncommon gastrointestinal ulcers, potentially with bleeding and perforation, stomatitis, exacerbation of colitis and Crohn's disease, gastritis.
Other adverse effects are: Uncommon: inflammation of the oral mucosa with ulcer formation. Rare: esophageal inflammation, esophageal stricture, exacerbation of diverticular disease, hemorrhagic colitis. Very rare: esophagitis, pancreatitis, intestinal stenosis.
Cardiac and vascular disorders
Medications like ibuprofeno may be associated with a moderate increase in the risk of suffering a heart attack or stroke.
Edema, hypertension, and heart failure have also been observed in association with treatments with medications of the ibuprofeno type.
Disorders of the skin and subcutaneous tissue
Medications like ibuprofeno may be associated, in very rare cases, with severe blistering reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis. Other adverse effects are:
Frequent: skin rash. Uncommon: skin redness, itching or swelling of the skin, purpura. Very rare: hair loss, erythema multiforme, skin reactions due to light influence, inflammation of blood vessels in the skin. Exceptionally, severe skin infections and soft tissue complications may occur during chickenpox.
Frequency not known: skin becomes sensitive to light. Generalized red scaly rash, with bumps under the skin and blisters, mainly located in skin folds, trunk, and upper limbs, accompanied by fever at the start of treatment. Stop taking this medication if you experience these symptoms and seek immediate medical attention. See also section 2.
Disorders of the immune system
Uncommon: hypersensitivity reactions with skin rash and itching, as well as asthma attacks. Very rare: severe hypersensitivity reactions.
Note: In the event of these symptoms, which can occur with the first use, immediate medical attention is required.
Disorders of the nervous system
Frequent: fatigue or drowsiness, headache, and dizziness or instability. Uncommon: headache, dizziness. Rare: paresthesia. Very rare: aseptic meningitis. In most cases where aseptic meningitis has been reported with ibuprofeno, the patient suffered from some form of autoimmune disease, which was a risk factor.
Psychiatric disorders
Uncommon: insomnia, anxiety, restlessness. Rare: disorientation or confusion, nervousness, irritability. Very rare: psychotic reactions, depression.
Disorders of the ear and labyrinth
Frequent: vertigo. Uncommon: ringing or buzzing in the ears. Rare: hearing difficulty.
Ocular disorders
Uncommon: vision changes. Rare: abnormal or blurred vision.
Disorders of the blood and lymphatic system
Rare: decreased platelets, decreased white blood cells, decreased red blood cells, decreased granulocytes, pancytopenia, agranulocytosis, aplastic anemia, or hemolytic anemia. The first symptoms are: fever, sore throat, superficial ulcers in the mouth, flu-like symptoms, extreme fatigue, nosebleeds, and skin bleeding. Very rare: prolonged bleeding time.
Renal and urinary disorders
Very rare: edema; renal tissue damage; increased serum uric acid concentration.
Hepatobiliary disorders
Medications like ibuprofeno may be associated, in rare cases, with liver damage. Other rare adverse effects are: hepatitis, abnormal liver function, and jaundice. Very rare: liver dysfunction, liver damage, liver failure, acute hepatitis. Frequency unknown: liver failure.
General disorders
Worsening of inflammation during infectious processes.
To date, no serious allergic reactions have been reported with this medication, although they cannot be ruled out. The manifestations of this type of reaction could be fever, skin rash, abdominal pain, severe and persistent headache, nausea, vomiting, swelling of the face, tongue, and throat, difficulty breathing, asthma, palpitations, hypotension, or shock.
A severe skin reaction known as DRESS syndrome may occur. The symptoms of DRESS syndrome include: skin rash, lymph node inflammation, and elevated eosinophils.
If any of the following adverse effects occur, discontinue treatment and seek immediate medical attention:
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not store at a temperature above 30°C.
Keep the blister and/or bottle in the outer packaging to protect it from light.
Do not use this medication after the expiration date shown on the packaging after "CAD". The expiration date is the last day of the month indicated.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE Point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
The active ingredient is ibuprofeno. Each film-coated tablet contains 600 mg of ibuprofeno.
The other ingredients are:
Appearance of Ibuprofeno Vegal and package contents
White, oval, biconvex film-coated tablets.
It is packaged in HDPE bottles with 40 tablets and in PVC-PVDC/aluminum blisters with 40 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder
Vegal Farmaceutica, S.L.
Vía de las Dos Castillas 9C, portal 2, 2ºC.
28224 Pozuelo de Alarcón, Madrid, Spain.
Manufacturer
Teva Pharma, S.L.U.
Polígono Malpica. Calle C nº 4.
50016 Zaragoza, Spain.
or
SAG Manufacturing S.L.U.
Ctra. N-I, Km 36.
28750 San Agustín de Guadalix.
Madrid, Spain.
Date of the last revision of this prospectus:March 2023.
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.